Glenn M. Chertow

Dr. Chertow, MD, MPH, is Professor of Medicine and Chief of the Division of Nephrology at Stanford University School of Medicine. Prior to joining the faculty at Stanford, Dr. Chertow served with distinction on the faculties at Brigham and Women’s Hospital and Harvard Medical School (1995-98) and the University of California San Francisco (UCSF) (1998-2007). Dr. Chertow has established a successful career as a clinical investigator and continues to maintain a productive research program focused on improving care for persons with acute and chronic kidney disease. Recent projects include several NIDDK-sponsored initiatives: Acute Renal Failure Trials Network (ATN) Study, the United States Renal Data System (USRDS) Special Studies Center in Nutrition, the Chronic Renal Insufficiency Cohort (CRIC) study and the Frequent Hemodialysis Network (FHN) study. Dr. Chertow was elected to the National Academy of Medicine in 2015, one of the only nephrologists among the academy’s more than 2,000 distinguished members who are elected in recognition of professional achievement and commitment to service. He was elected to the American Society of Clinical Investigation in 2004 and appointed to the Scientific Advisory Board of the National Kidney Foundation in 2007. He was Vice Chair and member of two workgroups for the Kidney Disease Quality Outcomes Initiative (K/DOQI) and Associate Editor of the Journal of the American Society of Nephrology. Dr. Chertow has authored more than 400 medical publications, and is an editor of the 9th edition of Brenner & Rector’s The Kidney. Dr. Chertow also received the 2007 National Torchbearer Award from the American Kidney Fund for his career-long contributions toward improving the lives of persons with kidney disease. Dr. Chertow received his medical degree from Harvard Medical School, his Master of Public Health from the Harvard School of Public Health in epidemiology and biostatistics, performed his residency and fellowship at Brigham and Women’s Hospital, Harvard Medical School, and is board certified in nephrology. His major medical research interests include clinical epidemiology, health services research, decision sciences, and clinical trials in acute and chronic kidney disease.